Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Morgan Stanley Maintains Overweight on PACCAR

Morgan Stanley Maintains Overweight on PACCAR

Morgan Stanley analyst Dillon Cumming maintains PACCAR (NASDAQ:PCAR) with a Overweight.

byBenzinga Newsdesk

February 8, 2023

1 minute read

Morgan Stanley analyst Dillon Cumming maintains PACCAR (NASDAQ:PCAR) with a Overweight.

Analyst Ratings

Analyst Scoreboard: 11 Ratings For Albemarle

By Benzinga Insights

February 15, 5:00 PM

In the last three months, 11 analysts have published ratings on Albemarle (NYSE:ALB), offering a diverse range of…

ALB

Analyst Ratings

The Latest Analyst Ratings for BeiGene

By Benzinga Insights

September 12, 11:00 AM

Over the past 3 months, 7 analysts have published their opinion on BeiGene (NASDAQ:BGNE) stock. These analysts are…

BGNE

Verint Systems’ AI-Driven CX Automation To Curb Rising Labor Costs: Needham Analyst

By Nabaparna Bhattacharya

June 14, 2:03 PM

Needham analyst Ryan MacDonald reiterated a Buy rating on Verint Systems Inc. (NASDAQ: VRNT) with a

VRNT

Small Pharma Implements Cost-Cutting Strategy To Reduce Cash Burn As Trial Progresses

By Lara Goldstein

June 29, 2:55 PM

UK-based biotech firm Small Pharma Inc. (OTCQB: DMTTF) shared its financial outcomes for the fiscal year ended Feb. 28, plus pipeline updates. Highlights:

DMTTF

Morgan Stanley Maintains Overweight on PACCAR

Related Posts

Analyst Scoreboard: 11 Ratings For Albemarle

The Latest Analyst Ratings for BeiGene

Verint Systems’ AI-Driven CX Automation To Curb Rising Labor Costs: Needham Analyst

Small Pharma Implements Cost-Cutting Strategy To Reduce Cash Burn As Trial Progresses